Luja Coude
Payments companies reported to CMS as associated with Luja Coude. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Luja Coude, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Luja Coude
These are the largest totals companies reported as associated with Luja Coude. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Kennelly | Charlotte, NC | Urology | $74,740.61 |
| Alvaro Lucioni | Seattle, WA | Urology | $35,830.27 |
| Ty Erickson | Idaho Falls, ID | Obstetrics & Gynecology | $20,707.96 |
| Paul Chung | Philadelphia, PA | Urology | $6,048.40 |
| Alexey Levashkevich | Flint, MI | Obstetrics | $5,850.13 |
| Srinivas Ivatury | Lebanon, NH | Colon & Rectal Surgery | $5,610.00 |
| Diane Newman | Philadelphia, PA | Adult Health (Nurse Practitioner) | $3,570.00 |
| Lucas Wiegand | Orlando, FL | Urology | $3,179.81 |
| Christina Hicks | Dallas, TX | Women'S Health (Nurse Practitioner) | $3,145.81 |
| Margaret Hull | Nashville, TN | Women'S Health (Nurse Practitioner) | $3,069.91 |
Prescribed Luja Coude?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.